腺病毒βARKct心脏基因转移减轻猪心脏骤停复苏后心肌损伤
该研究在雄性长白家猪心脏骤停模型中,将动物随机分为假手术组(n=4)、对照组(室颤8分钟,n=8)和βARKct组(室颤8分钟,n=8),通过腺病毒βARKct进行心脏基因转移抑制GRK2。结果显示,与对照组相比,βARKct治疗在复苏后6小时产生更好的左心室+dp/dtmax、-dp/dtmax、心输出量和射血分数,并降低血清心肌肌钙蛋白I、CK-MB和乳酸水平。机制上,βARKct基因转移显著增加β1肾上腺素能受体、SERCA2a、RyR2水平,并降低GRK2水平。作者结论认为,通过腺病毒βARKct心脏基因转移抑制GRK2可通过恢复肌浆网钙处理蛋白表达和上调β1肾上腺素能受体水平来改善复苏后心肌损伤。
要点
- 在猪室颤8分钟心脏骤停模型中,腺病毒βARKct心脏基因转移组复苏后6小时左心室+dp/dtmax、-dp/dtmax、心输出量和射血分数均优于对照组。
- βARKct治疗组复苏后血清心肌肌钙蛋白I、CK-MB和乳酸水平低于对照组。
- βARKct基因转移显著增加心脏β1肾上腺素能受体、SERCA2a、RyR2水平,并降低GRK2水平。
- 该研究为动物实验,样本量小(假手术组n=4,对照组n=8,βARKct组n=8),结论需进一步研究验证。
适用人群与场景
- 雄性长白家猪,心脏骤停模型(室颤8分钟),用于研究复苏后心肌损伤。
研究设计与关键结果
- 研究类型:动物实验(猪心脏骤停模型),样本量:假手术组n=4、对照组n=8、βARKct组n=8。
- 干预与对照:对照组室颤8分钟;βARKct组室颤8分钟并接受腺病毒βARKct心脏基因转移;假手术组麻醉和仪器监测但不诱导室颤。
- 主要终点结果:与假手术组相比,对照组和βARKct组复苏后6小时左心室+dp/dtmax、-dp/dtmax、心输出量和射血分数均显著降低;但βARKct治疗组复苏后这些指标优于对照组。
- 关键次要终点:βARKct治疗组复苏后血清心肌肌钙蛋白I、CK-MB和乳酸水平低于对照组。
- 机制结果:与对照组相比,腺病毒βARKct基因转移显著增加β1肾上腺素能受体、SERCA2a、RyR2水平,并降低GRK2水平。
证据类型、等级与局限
- 证据类型:动物实验(猪心脏骤停模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of the study was to determine whether the inhibition of the G-protein-coupled receptor kinase 2 by adenoviral βARKct cardiac gene transfer can ameliorate postresuscitation myocardial injury in pigs with cardiac arrest (CA) and explore the mechanism of myocardial protection.
METHODS: Male landrace domestic pigs were randomized into the sham group (anesthetized and instrumented, but ventricular fibrillation was not induced) (n = 4), control group (ventricular fibrillation 8 min, n = 8), and βARKct group (ventricular fibrillation 8 min, n = 8). Hemodynamic parameters were monitored continuously. Blood samples were collected at baseline, 30 min, 2 h, 4 h, and 6 h after the return of spontaneous circulation (ROSC). Left ventricular ejection fraction was assessed by echocardiography at baseline and 6 h after ROSC. These animals were euthanized, and the cardiac tissue was removed for analysis at 6 h after ROSC.
RESULTS: Compared with those in the sham group, left ventricular +dp/dtmax, -dp/dtmax, cardiac output (CO), and ejection fraction (EF) in the control group and the βARKct group were significantly decreased at 6 h after the restoration of spontaneous circulation. However, the βARKct treatment produced better left ventricular +dp/dtmax, -dp/dtmax, CO, and EF after ROSC. The βARKct treatment also produced lower serum cardiac troponin I, CK-MB, and lactate after ROSC. Furthermore, the adenoviral βARKct gene transfer significantly increased β1 adrenergic receptors, SERCA2a, RyR2 levels, and decreased GRK2 levels compared to control.
CONCLUSIONS: The inhibition of GRK2 by adenoviral βARKct cardiac gene transfer can ameliorate postresuscitation myocardial injury through beneficial effects on restoring the sarcoplasmic reticulum Ca-handling proteins expression and upregulating the β1-adrenergic receptor level after cardiac arrest.
参考来源
- Shang D, Zhu F, Tan Q, et al. Adenoviral βARKct Cardiac Gene Transfer Ameliorates Postresuscitation Myocardial Injury in a Porcine Model of Cardiac Arrest. Shock. 2019. PMID: 31725109. doi:10.1097/SHK.0000000000001320
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。